We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We want to know what you think about our proposal to Nasonex Allergy Control Nasal Spray available without prescription.
We have received a request under the Freedom of Information Act 2000 for the following: 1. Full details of licenses to prescribe diamorphine…
The MHRA has reminded healthcare professionals prescribing aripiprazole to be alert to the known risk of patients developing addictive gambling, following a rise in the number of reports received in 2023
Statistics related to community pharmacies and dispensing in Northern Ireland for quarter 2 of 2023/24.
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Employment Tribunal decision.
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
MHRA seeks views on the listing of prescription medicines exempted from the safety feature and non-prescription medicines that must bear the safety feature (MLX387).
This report presents activity and payment statistics related to Northern Ireland Community Pharmaceutical Services for quarter 4 2021/22.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).